ACI
EW icon

Advance Capital I’s Edwards Lifesciences EW Stock Holding History

Advance Capital I’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-22,800
Closed -$541K – 218
2015
Q1 		$541K Buy
+22,800
New +$512K 0.34% 146

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Advance Capital I's EW Position: Q2 2015 in Review

Advance Capital I sold out of Edwards Lifesciences (EW) in Q2 2015, closing a stake of 22,800 shares — an estimated $541K sold.

Advance Capital I first reported a position in EW in Q1 2015 and held it in 1 quarter. The position peaked at $541K in Q1 2015. 579 funds tracked by Wall St. Rank hold EW as of Q2 2015.

  • Advance Capital I reported no remaining Edwards Lifesciences position as of Q2 2015 after selling out during the quarter.
  • Advance Capital I sold 22,800 Edwards Lifesciences shares in Q2 2015, an estimated $541K.
  • Advance Capital I first reported a position in Edwards Lifesciences in Q1 2015 and held it in 1 quarter.
  • Advance Capital I's Edwards Lifesciences position peaked at $541K in Q1 2015.
  • 579 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2015.

Based on Advance Capital I's 13F filing for Q2 2015, filed 3 Aug 2015.